SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as discussions around international expansion with Japan and Azerbaijan, coupled with recent analyst upgrades, drive strong bullish sentiment. The community is actively discussing persistent buying on dips and potential short squeezes, balancing enthusiasm for its AI and defense sector tailwinds against valuation concerns.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to significant volatility driven by escalating Middle East tensions fueling demand for defense and drone technology, alongside mixed community reactions to its Teal unit reportedly not making the top 11 in a critical military Gauntlet competition. Investors are actively debating the impact of this development against broader contract opportunities and upcoming earnings, with many pointing to potential short squeezes and future maritime drone advancements.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is actively trending as the community eagerly anticipates the late-breaking presentation of its positive Phase 3 HOPE-3 data at the upcoming MDA Conference, which showed significant cardiac and muscle benefits for its Duchenne Muscular Dystrophy therapy. Investors are optimistic for accelerated FDA approval following the Clinical Study Report submission, with many discussing a potential short squeeze amidst ongoing scrutiny of the regulatory environment.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as its acquisition of BrewDog's global beverage assets ignites a community debate between strategic diversification and concerns over investing in a declining industry, all while the sector awaits the long-anticipated DEA Schedule III cannabis rescheduling decision.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending as the community debates recent interpretations suggesting the FDA has offered a more feasible "softball placebo" trial design for its Huntington's disease gene therapy, AMT-130, following earlier regulatory hurdles. This perceived shift is driving discussions around the stock's recovery potential and renewed optimism for the gene therapy's path forward amidst ongoing ethical considerations.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending after securing $2.15 billion in non-dilutive financing that explicitly confirms Oracle as a key hyperscaler tenant for its Polaris Forge 2 campus, alongside a massive $2.4 billion power generation contract. The community is buzzing with anticipation for further hyperscaler lease announcements, recognizing APLD's strengthened position in the AI infrastructure market as power becomes the new bottleneck.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing (BA) is trending amid widespread reports of a substantial commercial aircraft order from China, with discussions also highlighting its defense sector as geopolitical tensions rise. The community is actively weighing if these new orders will provide a lasting boost, citing historical "sell the news" reactions, production challenges, and questions about the true impact of defense contracts on the stock's performance.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending amidst escalating Middle East tensions, particularly concerning the Strait of Hormuz, which is fueling intense debate among traders over sustained supply disruption versus potential de-escalation and price interventions. The community is sharply divided between those anticipating significantly higher oil prices and those betting on a swift reversal, impacting broader market sentiment.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. is gaining traction following a "Buy" rating from Goldman Sachs, which underscored its pivotal role in the strengthening uranium and rare earth markets driven by national security and energy demands. The community is actively discussing bullish chart patterns, like a "cup and handle" formation, and anticipates significant long-term growth for this critical materials provider.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is actively trending after reporting strong earnings and highly optimistic multi-year guidance for accelerating AI-driven data center growth, which has spurred numerous analyst upgrades and fueled community discussion around its pivotal role in AI infrastructure. Investors are also keenly watching for potential S&P 500 inclusion, further amplifying market interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4?

Ironwood sees Linzess rebounding in 2026 despite soft Q4 results, helped by strong prescription demand and improved net pricing.

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, March 11th at 4:00 p.m. ET. A...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given an average recommendation of "Hold" by the eight ratings firms that are currently covering the company...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 10.1% - Time to Sell?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 10.1% - What's Next...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to "Hold" at Zacks Research

Zacks Research downgraded Ironwood Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research note on Wednesday...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Estimates By $0.03 EPS

Ironwood Pharmaceuticals (NASDAQ:IRWD - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, missing...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9.5% on Analyst Upgrade

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 9.5% Following Analyst Upgrade...

IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks

Ironwood swings to Q4 loss as revenues plunge 47% year over year, missing estimates and sending shares down.

Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target Raised to $10.00 at Citizens Jmp

Citizens Jmp boosted their price objective on Ironwood Pharmaceuticals from $8.00 to $10.00 and gave the stock a "market outperform" rating in a research note on Thursday...

GSA Capital Partners LLP Has $405,000 Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD

GSA Capital Partners LLP decreased its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 57.1% during the 3rd quarter, according to its most recent filing with the...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.25	--	--	N/A
Q4 '25	-$0.06	-$0.01	84.62%	BEAT
Q3 '25	$0.11	$0.23	117.51%	BEAT
Q2 '25	$0.02	$0.14	500.01%	BEAT
Q1 '25	-$0.14	-$0.23	-68.87%	MISSED

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest IRWD News

IRWDIronwood Pharmaceuticals Inc - Ordinary Shares - Class A